Linscomb & Williams Inc. Lowers Position in The Allstate Co. (NYSE:ALL)

Linscomb & Williams Inc. reduced its stake in The Allstate Co. (NYSE:ALL) by 5.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 4,346 shares of the insurance provider’s stock after selling 248 shares during the quarter. Linscomb & Williams Inc.’s holdings in Allstate were worth $608,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Vanguard Group Inc. raised its position in Allstate by 11.5% in the 3rd quarter. Vanguard Group Inc. now owns 32,270,589 shares of the insurance provider’s stock valued at $3,595,266,000 after buying an additional 3,322,673 shares during the last quarter. Charles Schwab Investment Management Inc. increased its position in shares of Allstate by 3.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 5,926,917 shares of the insurance provider’s stock valued at $660,318,000 after purchasing an additional 172,250 shares during the last quarter. Invesco Ltd. increased its position in shares of Allstate by 46.6% during the 3rd quarter. Invesco Ltd. now owns 4,121,941 shares of the insurance provider’s stock valued at $459,225,000 after purchasing an additional 1,311,095 shares during the last quarter. Wellington Management Group LLP increased its position in shares of Allstate by 2.1% during the 3rd quarter. Wellington Management Group LLP now owns 3,831,852 shares of the insurance provider’s stock valued at $426,907,000 after purchasing an additional 77,295 shares during the last quarter. Finally, Morgan Stanley increased its position in shares of Allstate by 16.9% during the 3rd quarter. Morgan Stanley now owns 3,701,607 shares of the insurance provider’s stock valued at $412,396,000 after purchasing an additional 536,137 shares during the last quarter. 76.47% of the stock is owned by hedge funds and other institutional investors.

Allstate Price Performance

Shares of ALL traded up $0.84 during midday trading on Friday, hitting $164.84. 988,501 shares of the company traded hands, compared to its average volume of 1,404,019. The stock has a 50-day moving average of $169.02 and a 200-day moving average of $155.48. The Allstate Co. has a one year low of $100.57 and a one year high of $177.37. The firm has a market cap of $43.50 billion, a P/E ratio of 36.39, a PEG ratio of 1.55 and a beta of 0.51. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.36 and a quick ratio of 0.36.

Allstate (NYSE:ALL) last issued its quarterly earnings data on Thursday, May 2nd. The insurance provider reported $5.13 EPS for the quarter, topping the consensus estimate of $4.11 by $1.02. Allstate had a return on equity of 14.44% and a net margin of 2.31%. The company had revenue of $15.26 billion during the quarter, compared to analyst estimates of $12.76 billion. During the same quarter in the previous year, the firm earned ($1.30) earnings per share. Allstate’s revenue was up 10.7% on a year-over-year basis. As a group, sell-side analysts predict that The Allstate Co. will post 15.15 EPS for the current fiscal year.

Allstate Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, July 1st. Shareholders of record on Friday, May 31st will be paid a $0.92 dividend. This represents a $3.68 annualized dividend and a yield of 2.23%. The ex-dividend date is Friday, May 31st. Allstate’s dividend payout ratio is currently 81.24%.

Insiders Place Their Bets

In other Allstate news, CAO John C. Pintozzi sold 4,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 27th. The stock was sold at an average price of $159.47, for a total value of $637,880.00. Following the completion of the sale, the chief accounting officer now owns 10,736 shares of the company’s stock, valued at $1,712,069.92. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Allstate news, insider John E. Dugenske sold 31,000 shares of the business’s stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $170.20, for a total value of $5,276,200.00. Following the completion of the sale, the insider now owns 63,731 shares in the company, valued at $10,847,016.20. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO John C. Pintozzi sold 4,000 shares of the business’s stock in a transaction that occurred on Tuesday, February 27th. The shares were sold at an average price of $159.47, for a total value of $637,880.00. Following the completion of the sale, the chief accounting officer now owns 10,736 shares of the company’s stock, valued at approximately $1,712,069.92. The disclosure for this sale can be found here. 1.80% of the stock is owned by insiders.

Analysts Set New Price Targets

ALL has been the subject of several research analyst reports. TheStreet raised Allstate from a “c+” rating to a “b” rating in a research report on Wednesday, February 7th. The Goldman Sachs Group raised their target price on Allstate from $164.00 to $195.00 and gave the company a “buy” rating in a research report on Monday, March 25th. Wells Fargo & Company raised their target price on Allstate from $146.00 to $153.00 and gave the company an “underweight” rating in a research report on Friday, May 10th. Roth Mkm boosted their price objective on Allstate from $175.00 to $200.00 and gave the company a “buy” rating in a research note on Monday, April 8th. Finally, UBS Group boosted their price objective on Allstate from $171.00 to $185.00 and gave the company a “buy” rating in a research note on Monday, February 12th. One research analyst has rated the stock with a sell rating, three have given a hold rating, eleven have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Allstate presently has a consensus rating of “Moderate Buy” and an average price target of $174.59.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.